Gyala Therapeutics (private company)

See something wrong or missing? Let us know
Offices:
Barcelona
Business model:
B2B
Investors:
we tracked 1 investor
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 1 transaction

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Gyala Therapeutics is a spin off from Hospital Clínic – IDIBAPS (Barcelona) focused on developing new CAR-T therapies for treating hematological malignancies.

Companies with similar profile to Gyala Therapeutics:

CompanyCriteria
Spain Pulmobiotics S.L
66%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Invivo Capital
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Spain ARTHEx Biotech S.L.
66%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Invivo Capital
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Spain Oncoheroes Biosciences
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Spain Vytrus Biotech
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Sigrid Therapeutics
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Cirqle Biomedical
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Finland Sooma Medical
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Spain Algenex
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Biograil
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Scandinavian Real Hearts
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Spain ViveBiotech
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Particle 3D
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
  • Minim one investor from outside Scandinavia: Yes
Denmark InProTher
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Finland Optomed
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Spain Sanifit Therapeutics
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Iceland Alvotech
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Norway APIM Therapeutics
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Denmark AFYX Therapeutics
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Sweden EnginZyme
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Norway SonoClear
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD